http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101616872-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 |
| filingDate | 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101616872-B1 |
| titleOfInvention | Composition comprising hyperoside for preventing or treating sepsis |
| abstract | The present invention relates to a composition containing hyperoside, wherein the composition is excellent in the effect of inhibiting the expression of HMGB1 (high mobility group box 1) in vascular endothelial cells, and is useful as a pharmaceutical composition for preventing or treating sepsis And is useful as a health functional food for preventing or ameliorating sepsis. |
| priorityDate | 2014-07-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 57.